Estimates Revisions Middle East Pharmaceutical Industries Company
Stocks
4016
SA160G51UO10
Pharmaceuticals
|
Market Closed -
Saudi Arabian S.E.
05:50:00 15/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 65.40 SAR | -2.39% |
|
-2.53% | +2.92% |
| 27/08 | Avalon Pharma Reiterated at Overweight as Aljazira Capital Notes 'Solid' Q2 Growth | MT |
| 20/08 | Avalon Pharma Renews SAR50 Million Credit Facility | MT |
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | - | |||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
- Stock Market
- Stocks
- 4016 Stock
- Consensus Middle East Pharmaceutical Industries Company
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
